Viatris Inc. (VTRS)

US — Healthcare Sector
Peers: BHC  HLN  OGN  TAK  TEVA  ZTS 

Automate Your Wheel Strategy on VTRS

With Tiblio's Option Bot, you can configure your own wheel strategy including VTRS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol VTRS
  • Rev/Share 12.0069
  • Book/Share 13.1251
  • PB 0.6857
  • Debt/Equity 0.9238
  • CurrentRatio 1.6822
  • ROIC -0.0935

 

  • MktCap 10563120000.0
  • FreeCF/Share 1.5592
  • PFCF 5.6815
  • PE -2.8315
  • Debt/Assets 0.3758
  • DivYield 0.0533
  • ROE -0.206

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 5
  • P/B Score 4
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation VTRS Goldman -- Neutral -- $10 June 6, 2025

News

VTRS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead the Viatris Class Action Lawsuit
VTRS
Published: April 07, 2025 by: GlobeNewsWire
Sentiment: Neutral

SAN DIEGO, April 07, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Viatris Inc. (NASDAQ: VTRS) securities between August 8, 2024 and February 26, 2025, inclusive (the “Class Period”), have until June 3, 2025 to seek appointment as lead plaintiff of the Viatris class action lawsuit. Captioned Quinn v. Viatris Inc., No. 25-cv-00466 (W.D. Pa.), the Viatris class action lawsuit charges Viatris and certain of Viatris' top executives with violations of the Securities Exchange Act of 1934.

Read More
image for news VTRS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead the Viatris Class Action Lawsuit
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRS
VTRS
Published: April 04, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / April 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Viatris Inc. ("Viatris" or the "Company") (NASDAQ:VTRS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRS
Shareholders that Lost Money on Viatris Inc. (VTRS) Should Contact Levi & Korsinsky About Securities Fraud Investigation - VTRS
VTRS
Published: April 03, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. ("Viatris Inc.") (NASDAQ:VTRS) concerning possible violations of federal securities laws. Viatris issued a press release on February 27, 2025, reporting its fourth quarter and full year 2024 financial results, which missed consensus estimates with respect to key metrics.

Read More
image for news Shareholders that Lost Money on Viatris Inc. (VTRS) Should Contact Levi & Korsinsky About Securities Fraud Investigation - VTRS
VTRS Investors Have Opportunity to Join Viatris Inc. Fraud Investigation with the Schall Law Firm
VTRS
Published: April 03, 2025 by: PRNewsWire
Sentiment: Neutral

LOS ANGELES , April 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Viatris Inc. ("Viatris" or "the Company") (NASDAQ: VTRS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Read More
image for news VTRS Investors Have Opportunity to Join Viatris Inc. Fraud Investigation with the Schall Law Firm
Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS
VTRS
Published: April 03, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , April 3, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Viatris Inc. (NASDAQ: VTRS) resulting from allegations that Viatris may have issued materially misleading business information to the investing public. So What: If you purchased Viatris securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Read More
image for news Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS
ATTENTION Viatris Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
VTRS
Published: April 02, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. ("Viatris Inc.") (NASDAQ:VTRS) concerning possible violations of federal securities laws. Viatris issued a press release on February 27, 2025, reporting its fourth quarter and full year 2024 financial results, which missed consensus estimates with respect to key metrics.

Read More
image for news ATTENTION Viatris Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
Levi & Korsinsky Announces an Investigation on Behalf of Viatris Inc. (VTRS) Shareholders Who May Have Been Affected by Fraud
VTRS
Published: April 02, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. ("Viatris Inc.") (NASDAQ:VTRS) concerning possible violations of federal securities laws. Viatris issued a press release on February 27, 2025, reporting its fourth quarter and full year 2024 financial results, which missed consensus estimates with respect to key metrics.

Read More
image for news Levi & Korsinsky Announces an Investigation on Behalf of Viatris Inc. (VTRS) Shareholders Who May Have Been Affected by Fraud
Viatris Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - VTRS
VTRS
Published: April 01, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. ("Viatris Inc.") (NASDAQ:VTRS) concerning possible violations of federal securities laws. Viatris issued a press release on February 27, 2025, reporting its fourth quarter and full year 2024 financial results, which missed consensus estimates with respect to key metrics.

Read More
image for news Viatris Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - VTRS
An Investigation Has Commenced on Behalf of Viatris Inc. Shareholders. Contact Levi & Korsinsky to Discuss your VTRS Losses
VTRS
Published: March 31, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. ("Viatris Inc.") (NASDAQ:VTRS) concerning possible violations of federal securities laws. Viatris issued a press release on February 27, 2025, reporting its fourth quarter and full year 2024 financial results, which missed consensus estimates with respect to key metrics.

Read More
image for news An Investigation Has Commenced on Behalf of Viatris Inc. Shareholders. Contact Levi & Korsinsky to Discuss your VTRS Losses
Viatris Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - VTRS
VTRS
Published: March 31, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. ("Viatris Inc.") (NASDAQ:VTRS) concerning possible violations of federal securities laws. Viatris issued a press release on February 27, 2025, reporting its fourth quarter and full year 2024 financial results, which missed consensus estimates with respect to key metrics.

Read More
image for news Viatris Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - VTRS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRS
VTRS
Published: March 31, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , March 31, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRS
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
VTRS
Published: March 28, 2025 by: PRNewsWire
Sentiment: Neutral

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Viatris To Contact Him Directly To Discuss Their Options If you suffered significant losses in Viatris stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , March 28, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS).

Read More
image for news INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
Viatris Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - VTRS
VTRS
Published: March 27, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. ("Viatris Inc.") (NASDAQ:VTRS) concerning possible violations of federal securities laws. Viatris issued a press release on February 27, 2025, reporting its fourth quarter and full year 2024 financial results, which missed consensus estimates with respect to key metrics.

Read More
image for news Viatris Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - VTRS
Viatris Inc. Announcement: If You Have Suffered Losses in Viatris Inc. (NASDAQ: VTRS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
VTRS
Published: March 27, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Viatris Inc. (NASDAQ: VTRS) resulting from allegations that Viatris may have issued materially misleading business information to the investing public.

Read More
image for news Viatris Inc. Announcement: If You Have Suffered Losses in Viatris Inc. (NASDAQ: VTRS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRS
VTRS
Published: March 27, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Viatris Inc. ("Viatris" or the "Company") (NASDAQ:VTRS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRS
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Viatris Inc. (VTRS)
VTRS
Published: March 26, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. ("Viatris Inc.") (NASDAQ:VTRS) concerning possible violations of federal securities laws. Viatris issued a press release on February 27, 2025, reporting its fourth quarter and full year 2024 financial results, which missed consensus estimates with respect to key metrics.

Read More
image for news Levi & Korsinsky Investigates Possible Securities Fraud Violations by Viatris Inc. (VTRS)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRS
VTRS
Published: March 26, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Viatris Inc. (“Viatris” or the “Company”) (NASDAQ: VTRS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRS
Viatris Inc. (VTRS) Faces Investor Scrutiny After Possible Disclosure Delay About June 2024 FDA Inspection of Manufacturing Facility – Hagens Berman
VTRS
Published: March 25, 2025 by: GlobeNewsWire
Sentiment: Neutral

SAN FRANCISCO, March 25, 2025 (GLOBE NEWSWIRE) -- On February 27, 2025, investors saw the price of their shares of Viatris Inc. (NASDAQ: VTRS) tumble over 15% after the company disclosed an anticipated adverse 2025 monetary impact from the U.S. FDA's recent December 2024 determination concerning the company's oral dose manufacturing facility in Indore, India. Hagens Berman is investigating possible misconduct concerning the timing of Viatris' disclosures and urges investors who purchased Viatris shares and suffered substantial losses to submit your losses now.

Read More
image for news Viatris Inc. (VTRS) Faces Investor Scrutiny After Possible Disclosure Delay About June 2024 FDA Inspection of Manufacturing Facility – Hagens Berman
Viatris Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Viatris Inc. (VTRS)
VTRS
Published: March 24, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. ("Viatris Inc.") (NASDAQ:VTRS) concerning possible violations of federal securities laws. Viatris issued a press release on February 27, 2025, reporting its fourth quarter and full year 2024 financial results, which missed consensus estimates with respect to key metrics.

Read More
image for news Viatris Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Viatris Inc. (VTRS)
VTRS Investor News: Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS
VTRS
Published: March 24, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , March 24, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Viatris Inc. (NASDAQ: VTRS) resulting from allegations that Viatris may have issued materially misleading business information to the investing public. So What: If you purchased Viatris securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Read More
image for news VTRS Investor News: Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS
Viatris Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - VTRS
VTRS
Published: March 23, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. ("Viatris Inc.") (NASDAQ:VTRS) concerning possible violations of federal securities laws. Viatris issued a press release on February 27, 2025, reporting its fourth quarter and full year 2024 financial results, which missed consensus estimates with respect to key metrics.

Read More
image for news Viatris Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - VTRS
Shareholders That Lost Money on Viatris Inc.(VTRS) Should Contact Levi & Korsinsky about Securities Fraud Investigation - VTRS
VTRS
Published: March 21, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. ("Viatris Inc.") (NASDAQ:VTRS) concerning possible violations of federal securities laws. Viatris issued a press release on February 27, 2025, reporting its fourth quarter and full year 2024 financial results, which missed consensus estimates with respect to key metrics.

Read More
image for news Shareholders That Lost Money on Viatris Inc.(VTRS) Should Contact Levi & Korsinsky about Securities Fraud Investigation - VTRS
Viatris Inc. (VTRS) Faces Investor Scrutiny After Possible Disclosure Delay About June 2024 FDA Inspection of Manufacturing Facility – Hagens Berman
VTRS
Published: March 21, 2025 by: GlobeNewsWire
Sentiment: Neutral

SAN FRANCISCO, March 21, 2025 (GLOBE NEWSWIRE) -- On February 27, 2025, investors saw the price of their shares of Viatris Inc. (NASDAQ: VTRS) tumble over 15% after the company disclosed an anticipated adverse 2025 monetary impact from the U.S. FDA's recent December 2024 determination concerning the company's oral dose manufacturing facility in Indore, India.

Read More
image for news Viatris Inc. (VTRS) Faces Investor Scrutiny After Possible Disclosure Delay About June 2024 FDA Inspection of Manufacturing Facility – Hagens Berman
Viatris Inc. (VTRS) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
VTRS
Published: March 21, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. ("Viatris Inc.") (NASDAQ:VTRS) concerning possible violations of federal securities laws. Viatris issued a press release on February 27, 2025, reporting its fourth quarter and full year 2024 financial results, which missed consensus estimates with respect to key metrics.

Read More
image for news Viatris Inc. (VTRS) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS
VTRS
Published: March 21, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / March 21, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Viatris Inc.(NASDAQ:VTRS) resulting from allegations that Viatris may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Viatris securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Read More
image for news ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRS
VTRS
Published: March 21, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / March 21, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Viatris Inc. ("Viatris" or the "Company") (NASDAQ:VTRS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRS
Shareholder Rights Advocates at Levi & Korsinsky Investigate Viatris Inc. (VTRS) Regarding Possible Securities Fraud Violations
VTRS
Published: March 21, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. ("Viatris Inc.") (NASDAQ:VTRS) concerning possible violations of federal securities laws. Viatris issued a press release on February 27, 2025, reporting its fourth quarter and full year 2024 financial results, which missed consensus estimates with respect to key metrics.

Read More
image for news Shareholder Rights Advocates at Levi & Korsinsky Investigate Viatris Inc. (VTRS) Regarding Possible Securities Fraud Violations
Did Viatris Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - VTRS
VTRS
Published: March 19, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. ("Viatris Inc.") (NASDAQ:VTRS) concerning possible violations of federal securities laws. Viatris issued a press release on February 27, 2025, reporting its fourth quarter and full year 2024 financial results, which missed consensus estimates with respect to key metrics.

Read More
image for news Did Viatris Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - VTRS
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS
VTRS
Published: March 19, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 19, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Viatris Inc. (NASDAQ:VTRS) resulting from allegations that Viatris may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Viatris securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Read More
image for news ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS
Lost Money on Viatris Inc. (VTRS)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
VTRS
Published: March 19, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. ("Viatris Inc.") (NASDAQ:VTRS) concerning possible violations of federal securities laws. Viatris issued a press release on February 27, 2025, reporting its fourth quarter and full year 2024 financial results, which missed consensus estimates with respect to key metrics.

Read More
image for news Lost Money on Viatris Inc. (VTRS)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

About Viatris Inc. (VTRS)

  • IPO Date 1980-03-17
  • Website https://www.viatris.com
  • Industry Drug Manufacturers - Specialty & Generic
  • CEO Scott Andrew Smith
  • Employees 32000

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.